Postinfectious irritable bowel syndrome1
Section snippets
Epidemiology
One of the earliest reports of PI-IBS relates to unexplained diarrhea and abdominal discomfort seen in British troops returning from the World War II North Africa campaign after amebic dysentery.5 The term postdysenteric irritable bowel syndrome was first used by Chaudhary and Truelove,6 who described 130 cases of “irritable colon syndrome,” 34 of whom dated the onset of their symptoms to an attack of either bacillary or amebic dysentery. This retrospective survey suggested that such patients
References (72)
- et al.
Demographic and clinical characteristics of patients with irritable bowel syndrome (IBS) from three practice settings
Gastroenterology
(2000) - et al.
Irritable bowel syndrome—post Salmonella infection
J Infect
(1994) - et al.
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Lancet
(1996) - et al.
A cohort study of enteric campylobacter infection in children from birth to two years in Bangui (Central African Republic)
Trans R Soc Trop Med Hyg
(1990) - et al.
Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome
Gastroenterology
(1988) - et al.
Does non-dysenteric intestinal amoebiasis exist?
Lancet
(1997) - et al.
IL-10 and TGF-beta phenotype in irritable bowel syndromeevidence to support an inflammatory component (abstr)
Gastroenterology
(2000) - et al.
Preliminary reportrole of peptide YY in defence against diarrhoea
Lancet
(1990) - et al.
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease
Am J Gastroenterol
(2002) - et al.
Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice
Gastroenterology
(2001)
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
Gastroenterology
(2000)
Prucalopride accelerates small bowel and colonic transit in patients with chronic functional constipation (FC) or constipation-predominant irritable bowel syndrome (C-IBS)
Gastroenterology
(2000)
Role of serotonin in the immune system and in neuroimmune interactions
Brain Behav Immun
(1998)
Intestinal lactase deficiency and milk drinking capacity in the adult
Am J Clin Nutr
(1978)
Budesonide treatment for collagenous colitisa randomized, double-blind, placebo-controlled, multicenter trial
Gastroenterology
(2002)
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
Am J Gastroenterol
(2000)
Association of adult coeliac disease with irritable bowel syndromea case-control study in patients fulfilling ROME II criteria referred to secondary care
Lancet
(2001)
Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea
Gastroenterology
(1980)
Amitriptylin for the treatment of IBS
Gastroenterology
(2000)
Abnormal colonic fermentation in irritable bowel syndrome
Lancet
(1998)
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
Dig Liver Dis
(2000)
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
Am J Gastroenterol
(2000)
Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis
Gastroenterology
(1998)
Post Salmonella irritable bowel syndrome-5-year review
J Infect
(1996)
Prognosis in the irritable bowel syndromea 5-year prospective study
Lancet
(1987)
Significance of anxiety in IBS outpatientsrelation to bowel symptoms and final diagnosis
Gut
(2002)
Functional bowel disorders and functional abdominal pain
Gut
(1999)
Distinctive histological patterns of chronic inflammatory cells in rectal biopsies of patients with different clinical subtypes of IBS
Gastroenterology
(2002)
Post-dysenteric colitis
Br Med J
(1950)
The irritable colon syndrome
QJM
(1962)
The role of psychological and biological factors in postinfective gut dysfunction
Gut
(1999)
Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndromepostal survey of patients
BMJ
(1997)
Relationship of campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome
J Infect Dis
(2001)
Does infectious diarrhoea (ID) predispose people to functional gastro-intestinal disorders (FGIDs)? A prospective community case-control study
Gut
(2002)
Increased risk of irritable bowel syndrome after bacterial gastroenteritiscohort study
BMJ
(1999)
Study of infectious intestinal disease in Englandrates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive
Br Med J
(1999)
Cited by (0)
- 1
Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.
Copyright © 2003 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.